4Filing Date: Jan 5, 2026

Guardant Health (GH) 4: Freeman Chris bought 1,928 shares of Common Stock at $N/A o… (Jan 5, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001871615-26-000002
Total Value$1.04M
Trades12
Insiders1

Transaction Details

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+15.43K
Price$0.00
Total Value$0
Shares Owned After44.15K
Transaction DateJan 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.53K
Price$0.00
Total Value$0
Shares Owned After54.03K
Transaction DateJan 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Performance-Based Restricted Stock UnitsDerivative
Shares-5.69K
Price$0.00
Total Value$0
Shares Owned After5.69K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+5.69K
Price$0.00
Total Value$0
Shares Owned After51.51K
Transaction DateJan 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.93K
Price$0.00
Total Value$0
Shares Owned After5.79K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.93K
Price$0.00
Total Value$0
Shares Owned After28.72K
Transaction DateJan 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-10.16K
Price$102.14
Total Value$1.04M
Shares Owned After43.87K
Transaction DateJan 1, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.67K
Price$0.00
Total Value$0
Shares Owned After5.00K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-2.53K
Price$0.00
Total Value$0
Shares Owned After17.68K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.67K
Price$0.00
Total Value$0
Shares Owned After45.82K
Transaction DateJan 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Performance-Based Restricted Stock UnitsDerivative
Shares-15.43K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateJan 1, 2026
Footnotes ▸

This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Performance-Based Restricted Stock UnitsDerivative
Shares0
Price-
Total Value$0
Shares Owned After15.43K
Holding Only
Footnotes ▸

This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. | Not applicable for Restricted Stock Units.

Post-Transaction Holdings

Freeman Chris · Chief Commercial Officer
SecuritySharesChange
Common Stock44.15K+17.07K (63.06%)
Performance-Based Restricted Stock Units5.69K-21.12K (-78.78%)
Restricted Stock Units5.79K-6.12K (-51.41%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Freeman Chris CIK: 0001871615 Role: Officer (Chief Commercial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +1,928 | Price: $0.00 Shares Owned After: 28,723 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +15,428 | Price: $0.00 Shares Owned After: 44,151 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +1,667 | Price: $0.00 Shares Owned After: 45,818 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +5,688 | Price: $0.00 Shares Owned After: 51,506 | Ownership: D (Direct) [Transaction #5] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +2,526 | Price: $0.00 Shares Owned After: 54,032 | Ownership: D (Direct) [Transaction #6] Security: Common Stock Date: 2026-01-01 | Code: F (Payment of exercise/tax) Shares: -10,162 | Price: $102.14 Total Value: $1,037,946.68 Shares Owned After: 43,870 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -1,928 | Price: $0.00 Shares Owned After: 5,786 | Ownership: D (Direct) Footnotes: [F2] This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Performance-Based Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -15,428 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F4] This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. [F3] Not applicable for Restricted Stock Units. [Transaction #3] Security: Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -1,667 | Price: $0.00 Shares Owned After: 5,002 | Ownership: D (Direct) Footnotes: [F5] This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #4] Security: Performance-Based Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -5,688 | Price: $0.00 Shares Owned After: 5,688 | Ownership: D (Direct) Footnotes: [F6] This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. [F3] Not applicable for Restricted Stock Units. [Transaction #5] Security: Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -2,526 | Price: $0.00 Shares Owned After: 17,684 | Ownership: D (Direct) Footnotes: [F7] This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Holdings --- [Holding #1] Security: Performance-Based Restricted Stock Units Ownership: D (Direct) Footnotes: [F4] This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. F4: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. F5: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F6: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. F7: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Chris Freeman (2026-01-05)

keid analysis is for reference only and does not constitute investment advice.